一项国际研究结果显示,抗癌药物蓓萨罗丁在动物实验中成功降低了阿尔茨海默氏症患病风险。据此,研究人员有望开发出预防这种神经系统退行性疾病的药物。发表在新一期美国《科学进展》杂志上的研究报告介绍说,英国剑桥大学研究人员与瑞典、荷兰的同行利用基因技术,在实验中使线虫具有患上阿尔茨海默氏症的风险,然后给它们喂食一定剂量的蓓萨罗 An international study showed that the anticancer drug bexarotene successfully reduced the risk of Alzheimer’s disease in animal experiments. As a result, researchers are expected to develop drugs to prevent this degenerative disease of the nervous system. Published in the new issue of the United States, “Science Progress” magazine, the study reported that researchers at the University of Cambridge and Sweden, Netherlands, colleagues using genetic technology in the experiment so that nematodes have the risk of Alzheimer’s disease, Then give them a dose of Bexarotene